Advances in Biomarker Research in Parkinson’s Disease

Developments in the Role of Transcranial Sonography for the Differential Diagnosis of Parkinsonism

(2015) Andrea Pilotto et al.   Current Neurology and Neuroscience Reports

Can we use peripheral tissue biopsies to diagnose Parkinson's disease? A review of the literature

(2015) S. A. Schneider et al.   EUROPEAN JOURNAL OF NEUROLOGY

Identification of novel biomarkers for Parkinson's disease by metabolomic technologies

(2015) Taku Hatano et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Gastrointestinal dysfunction in Parkinson's disease

(2015) Alfonso Fasano et al.   LANCET NEUROLOGY

CSF proteins and resting-state functional connectivity in Parkinson disease

(2015) M. C. Campbell et al.   NEUROLOGY

Parkinson risk in idiopathic REM sleep behavior disorder: Preparing for neuroprotective trials

(2015) R. B. Postuma et al.   NEUROLOGY

Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers

(2015) Claustre Pont-Sunyer et al.   PLoS One

Mendelian randomization of serum urate and parkinson disease progression

(2014) Kelly Claire Simon et al.   ANNALS OF NEUROLOGY

Neuroimaging biomarkers for Parkinson disease: Facts and fantasy

(2014) Joel S. Perlmutter et al.   ANNALS OF NEUROLOGY

CSF A 42 predicts early-onset dementia in Parkinson disease

(2014) G. Alves et al.   NEUROLOGY

Submandibular gland needle biopsy for the diagnosis of Parkinson disease

(2014) C. H. Adler et al.   NEUROLOGY

CSF biomarkers and clinical progression of Parkinson disease

(2014) S. Hall et al.   NEUROLOGY

Low clinical diagnostic accuracy of early vs advanced Parkinson disease: Clinicopathologic study

(2014) C. H. Adler et al.   NEUROLOGY

Olfactory dysfunction in incidental Lewy body disease and Parkinson's disease

(2014) Erika Driver-Dunckley et al.   PARKINSONISM & RELATED DISORDERS

Inosine to Increase Serum and Cerebrospinal Fluid Urate in Parkinson Disease

(2014) Michael A. Schwarzschild et al.   JAMA Neurology

Recent developments in biomarkers in Parkinson disease

(2013) Anthony H.V. Schapira   CURRENT OPINION IN NEUROLOGY

Cerebrospinal fluid α-synuclein levels in Parkinson's disease - changed or unchanged?

(2013) H. Zetterberg et al.   EUROPEAN JOURNAL OF NEUROLOGY

Submandibular Gland Biopsy for the Diagnosis of Parkinson Disease

(2013) Thomas G. Beach et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis

(2013) Peter A. LeWitt et al.   MOVEMENT DISORDERS

Blood-based biomarkers for Parkinson's disease

(2013) Lama M. Chahine et al.   PARKINSONISM & RELATED DISORDERS

EFNS/MDS-ES recommendations for the diagnosis of Parkinson's disease

(2012) A. Berardelli et al.   EUROPEAN JOURNAL OF NEUROLOGY

The PRIPS study: screening battery for subjects at risk for Parkinson's disease

(2012) D. Berg et al.   EUROPEAN JOURNAL OF NEUROLOGY

Enlarged Substantia Nigra Hyperechogenicity and Risk for Parkinson Disease

(2011) Daniela Berg   ARCHIVES OF NEUROLOGY

Diagnostic markers for Parkinsonʼs disease

(2011) Lama M. Chahine et al.   CURRENT OPINION IN NEUROLOGY

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

(2011) Brit Mollenhauer et al.   LANCET NEUROLOGY

The Parkinson Progression Marker Initiative (PPMI)

(2011) Kenneth Marek et al.   PROGRESS IN NEUROBIOLOGY

Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders

(2010) Thomas G. Beach et al.   ACTA NEUROPATHOLOGICA

Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson’s disease

(2010) Kelly Del Tredici et al.   ACTA NEUROPATHOLOGICA

Biomarkers in Parkinson’s Disease

(2010) John C. Morgan et al.   Current Neurology and Neuroscience Reports

Reproducibility and diagnostic accuracy of substantia nigra sonography for the diagnosis of Parkinson's disease

(2010) S. van de Loo et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Parkinson's at risk syndrome: Can Parkinson's disease be predicted?

(2010) Matthew B. Stern et al.   MOVEMENT DISORDERS

Incidental Lewy body disease: Clinical comparison to a control cohort

(2010) Charles H. Adler et al.   MOVEMENT DISORDERS

Severity of REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson disease

(2010) R. B. Postuma et al.   NEUROLOGY

CSF amyloid   1-42 predicts cognitive decline in Parkinson disease

(2010) A. Siderowf et al.   NEUROLOGY

Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease

(2010) Min Shi et al.   NEUROSCIENCE LETTERS

Relevance of substantia nigra hyperechogenicity and reduced odor identification in idiopathic REM sleep behavior disorder

(2010) Masaoki Iwanami et al.   SLEEP MEDICINE

Midbrain hyperechogenicity in idiopathic REM sleep behavior disorder

(2009) Heike Stockner et al.   MOVEMENT DISORDERS

Olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders

(2008) Thomas G. Beach et al.   ACTA NEUROPATHOLOGICA

Serum Urate as a Predictor of Clinical and Radiographic Progression in Parkinson Disease

(2008) Michael A. Schwarzschild   ARCHIVES OF NEUROLOGY